TNXP | Woo Trader

ATNXP - Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp. is a specialty pharmaceutical company focused on developing new pharmaceutical products for CNS conditions. The Company develops therapies for disorders that include fibromyalgia syndrome and post-traumatic stress disorder. Its lead product candidates include TNX-102, for the management of fibromyalgia syndrome and TNX-105 to treat symptoms of post-traumatic stress disorder. Tonix Pharmaceuticals Holding Corp. is headquartered in New York.

Last Close	$4.58^-0.87%	Range	$4.45-$4.70
Volume	62,100^-48%	Market Cap	$34.39 M
Avg Daily $	$549,115	Avg Volume	119,894
52 Week High	$9.40^-51%	52 Week Low	$0.33^+1,288%
Insider Score	No Activity	%Insiders	4%
%Institutions	29.97%	%M.F.	2.7%
Price Target	N/A	Mean Rating	Outperform
Zacks Target	$9.33^+104%	Zacks Rating	Strong Buy
TR Target	$6.00^+31%	TR Rating	Buy
News/Blogs	N/A	With Impact	N/A
Next Earnings	2017-11-09	Forward EPS	‑$0.68
EPS	-4.95	P/E	-0.93
Dividend	N/A	Yield	N/A

Wootrader.com is moving to https://financeboards.com - sign up for a free account.

ATNXP - Tonix Pharmaceuticals Holding Corp.

This full content is available for membership level Budding Investor or higher. You can register for a new account now.